Key parameters to be optimized in the development and manufacturing of oral solid-dosage forms.
| Published in: | Pharmaceutical Technology Vol. 41; no. 4; p. 18 |
|---|---|
| Main Author: | |
| Format: | Journal Article |
| Published: |
MJH Life Sciences
Apr2017
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=122469003&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 122469003 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15432521 4FK jtl: Pharmaceutical Technology issn: 15432521 maglogo: N pubinfo: dt: Apr2017 vid: 41 iid: 4 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 122469003 122469003 ppf: 18 ppct: 0 formats: fmt: @attributes: type: P tig: atl: Key parameters to be optimized in the development and manufacturing of oral solid-dosage forms. aug: au: Kane, Anil affil: Executive director, Global Head of Formulation Sciences, Pharmaceutical Development Services, Patheon sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|